John Shulman Net Worth & Insider Trades

John Shulman - Director, Petros Pharmaceuticals, Inc

As of January 3, 2022

What is John Shulman's Net Worth?

The current estimated net worth of Petros Pharmaceuticals, Inc's Director, John Shulman, is estimated to be about $5.16M . John Shulman owns about 5,703,544 units of Petros Pharmaceuticals, Inc common stock. In the last 2 years at Petros Pharmaceuticals, Inc, John Shulman has sold an estimated value of $0 worth.

What is John Shulman's Past Insider Trading?

John Shulman's largest purchase order was 1,661,807 units , worth over $2.85M on October 21, 2021. In total, John Shulman has made about 4 transactions over 2 years of their time at Petros Pharmaceuticals, Inc. John Shulman usually trades in January, November, October and December, with the busiest year in 2021. The most recent transaction was a purchase order of 145,773 units , worth over $500K on January 3, 2022.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

JOHN SHULMAN, JCP III SM AIV LP, METP Holdings LLC, Juggernaut Partners III GP LP, Juggernaut Partners III GP Ltd

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What are Petros Pharmaceuticals, Inc's Past Insider Trades?

Petros Pharmaceuticals, Inc's most recent insider trade came on January 3, 2022 by John Shulman, Jcp Iii SM Aiv Lp, Metp Holdings Llc, Juggernaut Partners Iii GP Lp and Juggernaut Partners Iii GP Ltd who bought 145,773 units worth $500K . In the last 2 months, insiders at Petros Pharmaceuticals, Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in April, with the busiest year in 2023. The most active traders at the company are Joshua Silverman, Director,  Bruce Bernstein, Director,  and Greg Bradley, Director .

Petros Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...